港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

同源康醫藥-B

6.295

-0.370-5.55%

成交量：228.65萬

成交額：1,454.16萬

市值：23.93億

市盈率：-6.75

高：6.580

開：6.400

低：6.200

收：6.665

52周最高：22.560

52周最低：5.350

股本：3.80億

香港流通股本：3.75億

量比：1.72

換手率：0.61%

股息：- -

股息率：- -

每股收益(LYR):-0.933

淨資產收益率：-70.66%

總資產收益率：-28.19%

市淨率：7.86

市盈率(LYR):-6.75

市銷率: 19180.08

資料載入中...

總覽公司新聞資訊公告

同源康醫藥-B（02410）將63,222,744股H股發行最後截止日期延至2026年9月20日

港股異動 | 同源康醫藥-B(02410)早盤升逾6% 上半年虧損顯著收窄 TY-9591商業化加速

智通财经网

同源康醫藥－Ｂ(02410)股價上升5.037%，現價港幣$7.09

阿斯达克财经

同源康醫藥-B(02410)上半年虧損大幅收窄產業化及商業化佈局持續取得進展

同源康醫藥-B（02410）披露董事會及四大委員會最新組成

同源康醫藥-B(02410.HK)：蔣鳴昱辭任非執行董事

同源康醫藥-B（02410）發布董事會變動及建議重選董事公告

創新藥概念繼續走強金斯瑞生物科技（01548）漲6.87% 機構指中國創新藥全球地位持續提升

同源康醫藥-B（02410）將於8月17日召開董事會審議2026年中期業績

同源康醫藥-B更新7月股份變動月報表，股本維持穩定

同源康醫藥-B午後升逾5% 齊魯製藥獲TY-9591獨家商業化授權

港股異動 | 同源康醫藥-B(02410.HK)午前升逾6% 齊魯製藥獲TY-9591獨家商業化授權擬股權投資同源康

同源康醫藥-B(02410)對四川匯宇製藥股份有限公司提起法律程序

同源康醫藥-B就TY-9591合作協議糾紛啓動法律程序

港股異動 | 同源康醫藥-B(02410.HK)高開近15% 與齊魯製藥達成戰略合作加速TY-9591商業化

同源康醫藥-B(02410)攜手齊魯推進新藥物TY-9591的開發、生產與商業化後者斥資4億元戰略入股

同源康醫藥-B（02410）擬獲齊魯製藥7億元人民幣首付款並以配股融資4億元人民幣

港股異動 | 同源康醫藥-B(02410)午後升逾15% 艾多替尼頭對頭擊敗奧希替尼預計將於三季度上市

港股同源康醫藥-B漲幅擴大至14%

每日经济新闻

同源康醫藥-B（02410）特別決議獲逾九成讚成通過發行授權

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/02410/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02410","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","market":"HK","secType":"STK","nameCN":"同源康醫藥-B","latestPrice":6.295,"timestamp":1787540374374,"preClose":6.665,"halted":0,"volume":2286500,"delay":0,"changeRate":-0.05551387846961742,"floatShares":375457818,"shares":380065818,"eps":-0.932632057502528,"marketStatus":"交易中","change":-0.37,"latestTime":"08-24 10:59:43","open":6.4,"high":6.58,"low":6.2,"amount":14541647,"amplitude":0.057014,"askPrice":6.31,"askSize":3000,"bidPrice":6.29,"bidSize":2500,"shortable":3,"etf":0,"ttmEps":-0.677908092587222,"tradingStatus":2,"nextMarketStatus":{"tag":"午間休市","tradingStatus":4,"beginTime":1787544000000},"marketStatusCode":2,"adr":0,"listingDate":1724083200000,"exchange":"SEHK","adjPreClose":6.665,"openAndCloseTimeList":[[1787535000000,1787544000000],[1787547600000,1787558400000]],"volumeRatio":1.715222,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","floatShares":375457818,"roa":"-28.19%","roe":"-70.66%","lyrEps":-0.932632,"volumeRatio":1.715222,"shares":380065818,"dividePrice":0,"high":6.58,"amplitude":0.057014,"preClose":6.665,"low":6.2,"week52Low":5.35,"pbRate":"7.86","psRate":"19180.08","week52High":22.56,"institutionHeld":0,"latestPrice":6.295,"committee":-0.090909,"eps":-0.932632057502528,"divideRate":0,"volume":2286500,"delay":0,"ttmEps":-0.677908092587222,"open":6.4,"prevYearClose":13.11,"prevWeekClose":6.665,"prevMonthClose":6.81,"prevQuarterClose":5.73,"fiveDayClose":6.75,"twentyDayClose":7.27,"sixtyDayClose":8.65},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02410\",params:#limit:5,,,undefined,":[{"date":"2026-08-17","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786930200000,"name":null,"time":"","dateTimestamp":1786896000000,"actualEps":null},{"date":"2026-03-30","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null},{"date":"2025-08-31","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756603800000,"name":null,"time":"","dateTimestamp":1756569600000,"actualEps":null},{"date":"2025-03-27","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743039000000,"name":null,"time":"","dateTimestamp":1743004800000,"actualEps":null},{"date":"2024-08-30","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724981400000,"name":null,"time":"","dateTimestamp":1724947200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02410\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02410\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02410\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02410","date":"2026-08-21","current":-9.28592,"percent":0.861789,"low":-45.171338,"twenty":-23.939778,"median":-17.197085,"eighty":-12.303816,"high":-6.195227,"avg":-18.106134,"sd":7.174161,"marketCap":2563850996},"quantilePoints":[{"date":"2024-08-23","current":-18.036629,"twenty":-16.647141,"median":-14.72623,"eighty":-12.008468,"marketCap":8010053668},{"date":"2024-08-30","current":-17.916348,"twenty":-18.108709,"median":-17.490261,"eighty":-14.277882,"marketCap":8010053668},{"date":"2024-09-06","current":-22.38992,"twenty":-20.387629,"median":-17.957821,"eighty":-15.985061,"marketCap":10531737231},{"date":"2024-09-13","current":-25.215246,"twenty":-24.52304,"median":-18.767123,"eighty":-16.911292,"marketCap":11829662594},{"date":"2024-09-20","current":-22.432724,"twenty":-24.518581,"median":-20.496807,"eighty":-17.208183,"marketCap":10587362603},{"date":"2024-09-27","current":-24.719835,"twenty":-24.497927,"median":-22.38992,"eighty":-17.671485,"marketCap":11736953639},{"date":"2024-10-04","current":-24.95032,"twenty":-24.87878,"median":-23.321155,"eighty":-17.932937,"marketCap":11792579012},{"date":"2024-10-10","current":-25.38933,"twenty":-24.941363,"median":-23.362473,"eighty":-17.973583,"marketCap":11922371548},{"date":"2024-10-18","current":-26.355956,"twenty":-25.311733,"median":-23.798709,"eighty":-18.108709,"marketCap":12311749157},{"date":"2024-10-25","current":-24.571342,"twenty":-25.374683,"median":-24.122054,"eighty":-18.545067,"marketCap":11477368567},{"date":"2024-11-01","current":-18.445843,"twenty":-25.311733,"median":-23.998666,"eighty":-18.584118,"marketCap":8621932768},{"date":"2024-11-08","current":-20.323115,"twenty":-25.278482,"median":-23.623818,"eighty":-17.973583,"marketCap":9456313359},{"date":"2024-11-15","current":-19.45318,"twenty":-25.171449,"median":-23.425489,"eighty":-18.108709,"marketCap":8955685004},{"date":"2024-11-22","current":-24.620137,"twenty":-24.988066,"median":-23.362473,"eighty":-18.406793,"marketCap":11329034239},{"date":"2024-11-29","current":-31.047836,"twenty":-25.311733,"median":-23.554037,"eighty":-18.584118,"marketCap":14277178993},{"date":"2024-12-06","current":-34.758675,"twenty":-25.786797,"median":-23.737743,"eighty":-19.168188,"marketCap":15945940174},{"date":"2024-12-13","current":-35.961329,"twenty":-26.0415,"median":-24.070769,"eighty":-19.324298,"marketCap":16465110319},{"date":"2024-12-20","current":-44.500897,"twenty":-30.298107,"median":-24.44033,"eighty":-19.494791,"marketCap":20284719244},{"date":"2024-12-27","current":-43.273475,"twenty":-31.455257,"median":-24.553474,"eighty":-19.619623,"marketCap":19709923726},{"date":"2025-01-03","current":-39.042242,"twenty":-33.760908,"median":-24.669986,"eighty":-19.709581,"marketCap":17800119264},{"date":"2025-01-10","current":-16.73771,"twenty":-34.083555,"median":-24.719835,"eighty":-19.709581,"marketCap":7602134269},{"date":"2025-01-17","current":-16.071561,"twenty":-33.760908,"median":-24.553474,"eighty":-18.860667,"marketCap":7305465614},{"date":"2025-01-24","current":-20.268382,"twenty":-32.413923,"median":-24.349989,"eighty":-19.230133,"marketCap":9270895450},{"date":"2025-01-28","current":-18.549699,"twenty":-31.591026,"median":-24.122054,"eighty":-18.549699,"marketCap":8529223814},{"date":"2025-02-07","current":-17.965815,"twenty":-31.472067,"median":-23.871541,"eighty":-18.275892,"marketCap":8214013368},{"date":"2025-02-14","current":-19.878813,"twenty":-31.451054,"median":-23.623818,"eighty":-18.275892,"marketCap":9066935750},{"date":"2025-02-21","current":-25.066745,"twenty":-31.047836,"median":-23.789321,"eighty":-18.32609,"marketCap":11495910358},{"date":"2025-02-28","current":-26.244856,"twenty":-30.411824,"median":-23.765234,"eighty":-18.39703,"marketCap":11996538712},{"date":"2025-03-07","current":-24.725844,"twenty":-30.135297,"median":-23.927628,"eighty":-18.445843,"marketCap":11347576030},{"date":"2025-03-14","current":-23.101371,"twenty":-29.84324,"median":-23.977848,"eighty":-18.549699,"marketCap":10605904394},{"date":"2025-03-21","current":-22.868028,"twenty":-28.789228,"median":-23.789321,"eighty":-18.691799,"marketCap":10494653649},{"date":"2025-03-28","current":-28.703724,"twenty":-28.703724,"median":-23.977848,"eighty":-19.110968,"marketCap":13146129748},{"date":"2025-04-03","current":-29.204856,"twenty":-29.744706,"median":-24.122054,"eighty":-19.131966,"marketCap":12070705875},{"date":"2025-04-11","current":-24.387234,"twenty":-29.307899,"median":-24.067881,"eighty":-19.145106,"marketCap":10012567086},{"date":"2025-04-17","current":-24.599189,"twenty":-28.955479,"median":-24.067881,"eighty":-19.224594,"marketCap":10123817831},{"date":"2025-04-25","current":-24.758022,"twenty":-28.755026,"median":-24.236021,"eighty":-19.282593,"marketCap":10197984995},{"date":"2025-05-02","current":-30.859428,"twenty":-28.772127,"median":-24.368612,"eighty":-19.308976,"marketCap":12738210348},{"date":"2025-05-09","current":-26.222368,"twenty":-28.789228,"median":-24.487968,"eighty":-19.376573,"marketCap":11477368567},{"date":"2025-05-16","current":-19.875071,"twenty":-28.703724,"median":-24.44033,"eighty":-19.45318,"marketCap":8770267095},{"date":"2025-05-23","current":-18.391406,"twenty":-28.460584,"median":-24.320388,"eighty":-19.147078,"marketCap":8139846205},{"date":"2025-05-30","current":-16.767615,"twenty":-28.328721,"median":-24.116277,"eighty":-18.777931,"marketCap":7453799941},{"date":"2025-06-06","current":-19.720458,"twenty":-27.077703,"median":-23.93026,"eighty":-18.847277,"marketCap":8788808886},{"date":"2025-06-13","current":-16.18601,"twenty":-26.697665,"median":-23.850097,"eighty":-18.709822,"marketCap":7216465018},{"date":"2025-06-20","current":-14.05098,"twenty":-26.664525,"median":-23.778892,"eighty":-18.426653,"marketCap":6252291891},{"date":"2025-06-27","current":-16.3221,"twenty":-26.630078,"median":-23.66211,"eighty":-18.32609,"marketCap":7283215465},{"date":"2025-07-04","current":-17.493079,"twenty":-26.41078,"median":-23.623818,"eighty":-18.194509,"marketCap":7806093968},{"date":"2025-07-11","current":-16.487526,"twenty":-26.267076,"median":-23.430941,"eighty":-17.964216,"marketCap":7349965912},{"date":"2025-07-18","current":-15.867745,"twenty":-26.226866,"median":-23.321155,"eighty":-17.866761,"marketCap":7068130691},{"date":"2025-07-25","current":-16.407488,"twenty":-26.143659,"median":-23.070409,"eighty":-17.335488,"marketCap":7335132480},{"date":"2025-08-01","current":-14.539711,"twenty":-26.072617,"median":-22.868028,"eighty":-17.325642,"marketCap":6459959949},{"date":"2025-08-08","current":-15.316665,"twenty":-25.987382,"median":-22.563641,"eighty":-17.04089,"marketCap":6822181433},{"date":"2025-08-15","current":-17.450454,"twenty":-25.968574,"median":-22.406203,"eighty":-16.915178,"marketCap":7760944003},{"date":"2025-08-22","current":-13.484776,"twenty":-25.95357,"median":-22.354126,"eighty":-16.718364,"marketCap":5978435317},{"date":"2025-08-29","current":-12.516323,"twenty":-25.925655,"median":-21.46252,"eighty":-16.486483,"marketCap":5575565550},{"date":"2025-09-05","current":-19.23268,"twenty":-25.919389,"median":-21.226743,"eighty":-16.486483,"marketCap":5883418862},{"date":"2025-09-12","current":-18.156363,"twenty":-25.850806,"median":-20.678772,"eighty":-16.541494,"marketCap":5564163575},{"date":"2025-09-19","current":-18.839434,"twenty":-25.807696,"median":-20.500943,"eighty":-16.56352,"marketCap":5769399117},{"date":"2025-09-26","current":-19.348832,"twenty":-25.743581,"median":-20.268382,"eighty":-16.654406,"marketCap":5910023469},{"date":"2025-10-03","current":-22.468168,"twenty":-25.650075,"median":-20.314843,"eighty":-16.707921,"marketCap":6879191305},{"date":"2025-10-10","current":-19.927643,"twenty":-25.596841,"median":-20.323115,"eighty":-16.732368,"marketCap":6092455062},{"date":"2025-10-17","current":-19.134493,"twenty":-25.519561,"median":-20.155539,"eighty":-16.749672,"marketCap":5845412280},{"date":"2025-10-24","current":-17.635142,"twenty":-25.404318,"median":-19.980008,"eighty":-16.781291,"marketCap":5389333299},{"date":"2025-10-31","current":-19.024541,"twenty":-25.400784,"median":-19.927643,"eighty":-16.830147,"marketCap":5822608331},{"date":"2025-11-07","current":-17.694439,"twenty":-25.37593,"median":-19.869193,"eighty":-16.945559,"marketCap":5412137248},{"date":"2025-11-14","current":-17.099248,"twenty":-25.321084,"median":-19.741813,"eighty":-16.951188,"marketCap":5244908288},{"date":"2025-11-21","current":-15.19815,"twenty":-25.311733,"median":-19.694587,"eighty":-16.919035,"marketCap":4659606928},{"date":"2025-11-28","current":-16.711808,"twenty":-25.293455,"median":-19.641679,"eighty":-16.730587,"marketCap":5142290517},{"date":"2025-12-05","current":-17.262657,"twenty":-25.275139,"median":-19.635782,"eighty":-16.587841,"marketCap":5320921452},{"date":"2025-12-12","current":-16.160016,"twenty":-25.213434,"median":-19.544821,"eighty":-16.497144,"marketCap":4990264190},{"date":"2025-12-19","current":-16.355316,"twenty":-25.19336,"median":-19.414876,"eighty":-16.454475,"marketCap":5062476695},{"date":"2025-12-24","current":-15.692499,"twenty":-25.154877,"median":-19.348832,"eighty":-16.406101,"marketCap":4872443786},{"date":"2026-01-02","current":-15.765099,"twenty":-25.10227,"median":-19.292077,"eighty":-16.35327,"marketCap":4914251026},{"date":"2026-01-09","current":-17.392186,"twenty":-25.070347,"median":-19.235279,"eighty":-16.345574,"marketCap":5434941197},{"date":"2026-01-16","current":-16.438751,"twenty":-25.06473,"median":-19.137216,"eighty":-16.35327,"marketCap":5153692492},{"date":"2026-01-23","current":-15.75073,"twenty":-25.023112,"median":-19.120814,"eighty":-16.314941,"marketCap":4933254317},{"date":"2026-01-30","current":-15.280433,"twenty":-24.971672,"median":-19.022068,"eighty":-16.22453,"marketCap":4807832597},{"date":"2026-02-06","current":-15.542994,"twenty":-24.952303,"median":-18.937078,"eighty":-16.152588,"marketCap":4902849052},{"date":"2026-02-13","current":-15.334427,"twenty":-24.923448,"median":-18.860882,"eighty":-16.099082,"marketCap":4864842470},{"date":"2026-02-20","current":-15.572498,"twenty":-24.905533,"median":-18.847277,"eighty":-16.071561,"marketCap":4933254317},{"date":"2026-02-27","current":-14.952615,"twenty":-24.827654,"median":-18.801141,"eighty":-15.988536,"marketCap":4788829306},{"date":"2026-03-06","current":-13.279596,"twenty":-24.77147,"median":-18.709822,"eighty":-15.892604,"marketCap":4218730579},{"date":"2026-03-13","current":-12.861452,"twenty":-24.760877,"median":-18.616931,"eighty":-15.828013,"marketCap":4104710834},{"date":"2026-03-20","current":-12.157235,"twenty":-24.758022,"median":-18.440891,"eighty":-15.765099,"marketCap":3865269369},{"date":"2026-03-27","current":-12.164275,"twenty":-24.758022,"median":-18.409208,"eighty":-15.692499,"marketCap":3857668052},{"date":"2026-04-02","current":-12.25818,"twenty":-24.73228,"median":-18.399621,"eighty":-15.606124,"marketCap":4180723998},{"date":"2026-04-10","current":-12.412577,"twenty":-24.72344,"median":-18.391406,"eighty":-15.554796,"marketCap":4266032641},{"date":"2026-04-17","current":-12.351427,"twenty":-24.717087,"median":-18.309793,"eighty":-15.461655,"marketCap":4246798950},{"date":"2026-04-24","current":-11.422185,"twenty":-24.709149,"median":-18.216326,"eighty":-15.337994,"marketCap":3927519681},{"date":"2026-04-30","current":-11.117278,"twenty":-24.702871,"median":-18.174743,"eighty":-15.304685,"marketCap":3823657750},{"date":"2026-05-08","current":-10.777891,"twenty":-24.684547,"median":-18.056929,"eighty":-15.189837,"marketCap":3719795820},{"date":"2026-05-15","current":-9.293361,"twenty":-24.617578,"median":-17.965815,"eighty":-15.119492,"marketCap":3215873118},{"date":"2026-05-22","current":-8.991533,"twenty":-24.605712,"median":-17.939574,"eighty":-15.043492,"marketCap":3104317711},{"date":"2026-05-29","current":-10.14843,"twenty":-24.599189,"median":-17.918048,"eighty":-14.961326,"marketCap":3515918696},{"date":"2026-06-05","current":-8.237808,"twenty":-24.571342,"median":-17.89208,"eighty":-14.895383,"marketCap":2858126467},{"date":"2026-06-12","current":-7.644268,"twenty":-24.535606,"median":-17.732128,"eighty":-14.684931,"marketCap":2650402606},{"date":"2026-06-18","current":-6.884404,"twenty":-24.459385,"median":-17.688347,"eighty":-14.384241,"marketCap":2392671147},{"date":"2026-06-26","current":-6.195227,"twenty":-24.397853,"median":-17.672452,"eighty":-13.470121,"marketCap":2142633166},{"date":"2026-07-03","current":-7.179757,"twenty":-24.364887,"median":-17.499062,"eighty":-13.369605,"marketCap":2484992864},{"date":"2026-07-10","current":-8.078806,"twenty":-24.314468,"median":-17.476751,"eighty":-13.262753,"marketCap":2792731918},{"date":"2026-07-17","current":-8.127776,"twenty":-24.232724,"median":-17.419476,"eighty":-13.079412,"marketCap":2819659085},{"date":"2026-07-24","current":-7.604914,"twenty":-24.150839,"median":-17.377721,"eighty":-12.93356,"marketCap":2638862391},{"date":"2026-07-31","current":-7.53517,"twenty":-24.119743,"median":-17.333807,"eighty":-12.87079,"marketCap":2619628700},{"date":"2026-08-07","current":-7.625479,"twenty":-24.07756,"median":-17.320685,"eighty":-12.528428,"marketCap":2656172713},{"date":"2026-08-14","current":-7.417307,"twenty":-24.00283,"median":-17.276309,"eighty":-12.375887,"marketCap":2586931426},{"date":"2026-08-21","current":-10.34776,"twenty":-23.939778,"median":-17.197085,"eighty":-12.303816,"marketCap":2563850996}],"updateTime":1787540383529},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02410\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1117102070","title":"同源康醫藥-B（02410）將63,222,744股H股發行最後截止日期延至2026年9月20日","url":"https://stock-news.laohu8.com/highlight/detail?id=1117102070","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117102070?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 19:21","pubTimestamp":1787224881,"startTime":"0","endTime":"0","summary":"浙江同源康医药股份有限公司8月20日发布公告称，公司与齐鲁方面就许可及合作事项下拟向认购方发行63,222,744股H股的认购协议，最后截止日期由2026年8月20日顺延至2026年9月20日。根据2026年7月21日公告，该认购事项须在认购协议项下的先决条件达成或获得豁免后方可完成；若相关条件未能在最后截止日期前落实，认购协议将被终止。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660459889","title":"港股異動 | 同源康醫藥-B(02410)早盤升逾6% 上半年虧損顯著收窄 TY-9591商業化加速","url":"https://stock-news.laohu8.com/highlight/detail?id=2660459889","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660459889?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 11:05","pubTimestamp":1787022306,"startTime":"0","endTime":"0","summary":"同源康医药-B(02410)早盘涨超6%，截至发稿，涨5.63%，报7.13港元，成交额1614.64万港元。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20260818/20260818110837_92055.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260818/20260818110837_92055.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1481199.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1574","02410","TY","BK4588","BK1161","159938","BK1515","BK4585","KCAI","09939","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660598564","title":"同源康醫藥－Ｂ(02410)股價上升5.037%，現價港幣$7.09","url":"https://stock-news.laohu8.com/highlight/detail?id=2660598564","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660598564?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 10:54","pubTimestamp":1787021640,"startTime":"0","endTime":"0","summary":"[上升股]同源康医药－Ｂ(02410) 股价在上午10:53比前收市价上升5.037%，现股价为港币$7.09。至目前为止，今日最高价为$7.09，而最低价为$6.62。总成交量为162.6万股，总成交金额为港币$1.124千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608181390/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608181390/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["09939","02410","BK1161","159938","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660806764","title":"同源康醫藥-B(02410)上半年虧損大幅收窄 產業化及商業化佈局持續取得進展","url":"https://stock-news.laohu8.com/highlight/detail?id=2660806764","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660806764?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 20:39","pubTimestamp":1786970394,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B 公布2026年中期业绩，研发成本为9494.3万元，同比增长7%;行政开支6255.4万元，同比增长61.3%;母公司拥有人应占亏损2489.7万元，同比收窄77.81%。此外，公司于2026年1月获浙江省药品监督管理局颁发的《药品生产许可证》。本次获得药品生产许可证，预期将对公司扩大产能及拓展市场产生长远的积极作用，为后续开展商业化生产奠定基础。此举为公司透过借助齐鲁的专业知识及网路达成其商业化里程碑的重要举措。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1480995.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","159938","02410","BK1515","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105087400","title":"同源康醫藥-B（02410）披露董事會及四大委員會最新組成","url":"https://stock-news.laohu8.com/highlight/detail?id=1105087400","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105087400?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 20:16","pubTimestamp":1786968984,"startTime":"0","endTime":"0","summary":"浙江同源康医药股份有限公司8月17日公告，公司董事会由九名董事组成，其中执行董事1名、非执行董事4名、独立非执行董事4名。本次公告日期为2026年8月17日，公司未对上述董事及委员会设置作出其他补充说明。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660504487","title":"同源康醫藥-B(02410.HK)：蔣鳴昱辭任非執行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2660504487","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660504487?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 20:10","pubTimestamp":1786968601,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02410","BK1515","BK1574","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182291744","title":"同源康醫藥-B（02410）發布董事會變動及建議重選董事公告","url":"https://stock-news.laohu8.com/highlight/detail?id=1182291744","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182291744?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 20:06","pubTimestamp":1786968373,"startTime":"0","endTime":"0","summary":"8月17日，同源康医药-B公告称，公司董事会收到蔣鸣昱博士的辞呈，其因投放更多时间从事其他商业事务，已辞任非执行董事及根据香港联交所证券上市规则第3.05条规定的授权代表，辞任自2026年8月17日起生效。蔣博士确认无任何与董事会及公司之间的意见分歧，亦无任何需提请股东及联交所关注的事项。董事会对其任职期间的贡献表示感谢。此外，公司将适时向股东派发载有建议重选董事详细资料的通函。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658369969","title":"創新藥概念繼續走強 金斯瑞生物科技（01548）漲6.87% 機構指中國創新藥全球地位持續提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2658369969","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658369969?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 11:15","pubTimestamp":1786418137,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股创新药概念持续走强，截至发稿，金斯瑞生物科技 涨6.87%，再鼎医药涨5.51%，同源康医药-B涨4.81%，晶泰控股涨3.94%，药明合联涨3.92%，翰森制药涨3.76%，亚盛医药涨3.63%，百济神州涨3.38%，药明康德涨3.03%，诺诚健华涨2.83%，石药集团涨2.78%。国元国际证券亦表示，出海交易量价齐升，中国创新药全球地位持续提升。中国创新药出海持续超预期，上半年997亿美元的交易总额和全球TOP10中独占8席的成绩，充分验证了中国创新药资产的全球竞争力。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250110/MmQ2MzI0NzdkYTM0MjU4ODU0NDE5OWM2MjQ0NmE1ZTExMDg1Mjk2Mjc3MDg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MmQ2MzI0NzdkYTM0MjU4ODU0NDE5OWM2MjQ0NmE1ZTExMDg1Mjk2Mjc3MDg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987912","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1588","09969","BK1515","LU1226288170.HKD","LU1226287792.SGD","LU2039709279.SGD","LU1152091168.USD","KURE","06160","BK1617","LU1993786604.SGD","HK0000306685.HKD","IE00BZ08YT58.USD","LU2488822045.USD","BK1521","BK1576","09688","LU1226287875.USD","06978","02359","03692","BK1500","BK1161","LU0880133367.SGD","LU2125910500.SGD","02410","LU0315179316.USD","LU1951186391.HKD","IBBQ","IE00B5MMRT66.SGD","IE00B543WZ88.USD","IE00BZ08YS42.EUR","LU1813983027.USD","02268","LU1303224171.USD","IE00BZ08YR35.GBP","LU0072913022.USD","01548","LNGR","06855","LU0326950275.SGD","01093","BK1583","MEDX","LU2328871848.SGD","HK0000320223.HKD","02228","159992","IE00B031HY20.USD","LU2242644610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104587482","title":"同源康醫藥-B（02410）將於8月17日召開董事會審議2026年中期業績","url":"https://stock-news.laohu8.com/highlight/detail?id=1104587482","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104587482?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 17:22","pubTimestamp":1785921722,"startTime":"0","endTime":"0","summary":"浙江同源康医药股份有限公司（股票代码：02410，股票简称：同源康医药-B）8月5日公告称，公司董事会会议将于2026年8月17日（星期一）举行。届时，董事会将审议并批准公司及其附属公司截至2026年6月30日止六个月的中期业绩，并讨论是否派发中期股息（如有）。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120386864","title":"同源康醫藥-B更新7月股份變動月報表，股本維持穩定","url":"https://stock-news.laohu8.com/highlight/detail?id=1120386864","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120386864?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 17:11","pubTimestamp":1785921109,"startTime":"0","endTime":"0","summary":"浙江同源康医药股份有限公司（同源康医药-B，股票代码：02410）于2026年8月5日发布截至2026年7月31日的股份变动月报表。报告显示，公司期末注册股本为人民币380,065,818元，各类已发行普通股合计380,065,818股，面值每股人民币1元，库藏股数量为0股。\n报告期内，公司无新增发行、购回、注销或库藏股变动，股本结构保持稳定。公司亦表示，其已满足香港联交所对于上市发行人最低公眾持股量不低于该类别股份总数的25%之规定。根据公告信息，本次月报由执行董事、董事长兼总裁吴豫生签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654972091","title":"同源康醫藥-B午後升逾5% 齊魯製藥獲TY-9591獨家商業化授權","url":"https://stock-news.laohu8.com/highlight/detail?id=2654972091","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654972091?lang=zh_tw&edition=fundamental","pubTime":"2026-07-27 13:12","pubTimestamp":1785129120,"startTime":"0","endTime":"0","summary":"　　同源康医药-B盘中涨超6%，截至发稿，股价上涨5.39%，现报7.23港元，成交额1757.17万港元。　　齐鲁制药获同源康医药肺癌靶向创新药TY-9591独家商业化授权，齐鲁制药还将对同源康医药进行股权投资。　　公开资料显示，TY-9591是同源康医药自主研发的新一代高选择性不可逆EGFR-TKI，也是国内差异化优势突出的肺癌靶向新药。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-07-27/doc-inikfnpf3106086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","01477","159938","BK1574","TY","09939","BK1161","BK1515","02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654109998","title":"港股異動 | 同源康醫藥-B(02410.HK)午前升逾6% 齊魯製藥獲TY-9591獨家商業化授權 擬股權投資同源康","url":"https://stock-news.laohu8.com/highlight/detail?id=2654109998","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654109998?lang=zh_tw&edition=fundamental","pubTime":"2026-07-27 11:56","pubTimestamp":1785124614,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","BK1515","09939","BK1191","02410","BK1574","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653698237","title":"同源康醫藥-B(02410)對四川匯宇製藥股份有限公司提起法律程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2653698237","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653698237?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 22:56","pubTimestamp":1784732193,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B 发布公告，本公司最近已向长兴县人民法院提交一宗案件，对四川汇宇制药股份有限公司(汇宇)提起法律程序，寻求以下司法确认：一份声称与汇宇订立的TY-9591相关合作协议及经销协议并未成立且属无效。本公司亦收到内江市市中区人民法院就汇宇就据称由本公司与汇宇订立的同一合作协议、经销协议及相关文件所发出的案件受理通知书。两宗案件均已立案，惟尚未在法院审理。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1471138.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01477","BK1574","02410","BK1515","BK1161","159938","09939","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105550769","title":"同源康醫藥-B就TY-9591合作協議糾紛啓動法律程序","url":"https://stock-news.laohu8.com/highlight/detail?id=1105550769","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105550769?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 22:55","pubTimestamp":1784732129,"startTime":"0","endTime":"0","summary":"浙江同源康医药股份有限公司7月22日发布公告称，公司已在长兴县人民法院对四川汇宇制药股份有限公司提起诉讼，要求法院确认双方所谓的TY-9591合作协议及经销协议“不成立且无效”。\\n\\n同源康医药-B同时透露，其亦收到内江市市中区人民法院就同一合作协议、经销协议及相关文件立案的受理通知书。两宗案件均已立案，但均尚未开庭审理。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653778219","title":"港股異動 | 同源康醫藥-B(02410.HK)高開近15% 與齊魯製藥達成戰略合作加速TY-9591商業化","url":"https://stock-news.laohu8.com/highlight/detail?id=2653778219","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653778219?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 09:24","pubTimestamp":1784683457,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","02410","01477","BK1574","BK1161","09939","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653274288","title":"同源康醫藥-B(02410)攜手齊魯推進新藥物TY-9591的開發、生產與商業化 後者斥資4億元戰略入股","url":"https://stock-news.laohu8.com/highlight/detail?id=2653274288","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653274288?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 19:28","pubTimestamp":1784633304,"startTime":"0","endTime":"0","summary":"认购方为齐鲁的全资附属公司，是齐鲁的投资控股平台。交易完成后齐鲁制药持股 14.26%。董事相信，与齐鲁的战略合作将进一步推进药物开发、生产与商业化进程。此举为公司透过借助齐鲁的专业知识及网络达成其商业化里程碑的重要举措。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1470504.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","09939","159938","BK1161","02410","BK1574","TY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113169040","title":"同源康醫藥-B（02410）擬獲齊魯製藥7億元人民幣首付款並以配股融資4億元人民幣","url":"https://stock-news.laohu8.com/highlight/detail?id=1113169040","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113169040?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 19:25","pubTimestamp":1784633151,"startTime":"0","endTime":"0","summary":"2026年7月21日，浙江同源康医药股份有限公司公告称，公司已于当日收市后与齐鲁制药（海南）有限公司及其指定关联方签署多份合作文件，并拟向齐鲁全资子公司Anchor International Limited定向增发H股。－ 同源康医药-B将获得3亿元人民币现金首付款，并可在TY-9591取得监管批准及适应症扩展后，获得最高20.6亿元人民币里程碑付款。－ 齐鲁或其关联方将同时通过认购H股向同源康医药-B支付约4亿元人民币，对应总首付款达7亿元人民币。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2653226476","title":"港股異動 | 同源康醫藥-B(02410)午後升逾15% 艾多替尼頭對頭擊敗奧希替尼 預計將於三季度上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2653226476","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653226476?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 13:43","pubTimestamp":1784612607,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同源康医药-B午后涨超15%，截至发稿，涨12.37%，报8.54港元，成交额5376.03万港元。消息面上，2026年ASCO大会上，同源康医药以LBA口头报告的形式，公布了艾多替尼用于EGFR突变非小细胞肺癌脑转移患者一线治疗的ESAONA研究期中分析结果。国海证券指出，艾多替尼在NSCLC脑转移患者中头对头击败奥希替尼，预计将于2026年第三季度上市。预计未来三年公司营收主要由TY9591贡献。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1470236.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02410","KCAI","BK1574","BK1515","BK4585","IPOS","09939","BK4588","VXUS","BK1161","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653223961","title":"港股同源康醫藥-B漲幅擴大至14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653223961","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653223961?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 11:46","pubTimestamp":1784605567,"startTime":"0","endTime":"0","summary":"【港股同源康医药-B涨幅扩大至14%】7月21日，港股同源康医药-B涨幅扩大至14%，报8.73港元/股，总市值33亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607213815173261.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607213815173261.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","BK1574","BK1161","BK4585","09939","02410","BK4588","KCAI","VXUS","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172333869","title":"同源康醫藥-B（02410）特別決議獲逾九成讚成通過發行授權","url":"https://stock-news.laohu8.com/highlight/detail?id=1172333869","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172333869?lang=zh_tw&edition=fundamental","pubTime":"2026-07-15 17:01","pubTimestamp":1784106100,"startTime":"0","endTime":"0","summary":"2026年7月15日，同源康医药-B公布2026年第一次临时股东大会投票结果。会上，公司就“发行股份的发行授权”提出的特别决议案获得135,580,001票赞成，占有效表决权的93.58%；反对票4,625,576票，占3.19%；弃权票4,681,502票，占3.23%。由于赞成票比例超过三分之二，相关决议正式获股东通过。截至会议当日，公司已发行股份总数为380,065,818股。本次会议的召集、召开及表决程序均符合中国公司法及公司章程的相关规定，香港中央证券登记有限公司担任监票机构。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":59,"code":"91000000","status":"200"}]}}